DK0521388T3 - Fremgangsmåde til fremstilling af et farmaceutisk præparat med mindst to forskellige aktivstoffer samt anvendelsen af et sådant præparat - Google Patents

Fremgangsmåde til fremstilling af et farmaceutisk præparat med mindst to forskellige aktivstoffer samt anvendelsen af et sådant præparat

Info

Publication number
DK0521388T3
DK0521388T3 DK92110679.5T DK92110679T DK0521388T3 DK 0521388 T3 DK0521388 T3 DK 0521388T3 DK 92110679 T DK92110679 T DK 92110679T DK 0521388 T3 DK0521388 T3 DK 0521388T3
Authority
DK
Denmark
Prior art keywords
mixtures
preparation
different
tablets
agents
Prior art date
Application number
DK92110679.5T
Other languages
English (en)
Inventor
Wolfram Dr Tritthart
Gerhard Dr Gergely
Original Assignee
Gergely Gerhard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gergely Gerhard filed Critical Gergely Gerhard
Application granted granted Critical
Publication of DK0521388T3 publication Critical patent/DK0521388T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK92110679.5T 1991-07-01 1992-06-25 Fremgangsmåde til fremstilling af et farmaceutisk præparat med mindst to forskellige aktivstoffer samt anvendelsen af et sådant præparat DK0521388T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH194491 1991-07-01

Publications (1)

Publication Number Publication Date
DK0521388T3 true DK0521388T3 (da) 1995-09-11

Family

ID=4222248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92110679.5T DK0521388T3 (da) 1991-07-01 1992-06-25 Fremgangsmåde til fremstilling af et farmaceutisk præparat med mindst to forskellige aktivstoffer samt anvendelsen af et sådant præparat

Country Status (8)

Country Link
US (1) US5393531A (da)
EP (1) EP0521388B1 (da)
JP (1) JPH05186332A (da)
AT (1) ATE122228T1 (da)
CA (1) CA2072533A1 (da)
DE (1) DE59202126D1 (da)
DK (1) DK0521388T3 (da)
ES (1) ES2074769T3 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
ZA963590B (en) * 1995-05-10 1996-11-19 Adcock Ingram Ltd Pharmaceutical composition
US5994348A (en) 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
EP1378234A1 (en) * 1996-05-17 2004-01-07 MERCK & CO. INC. Effervescent bisphosphonate formulation
EP0939624B1 (en) * 1996-05-17 2003-12-17 Merck & Co., Inc. Effervescent bisphosphonate formulation
EP1820497A3 (en) * 1996-05-17 2009-07-22 Merck & Co., Inc. Effervescent bisphosphonate formulation
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
SG109478A1 (en) * 1997-07-22 2005-03-30 Merck & Co Inc Method for inhibiting bone resorption
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
WO2001080895A2 (en) * 2000-04-26 2001-11-01 First Horizon Pharmaceutical Corporation Methods and compositions for the treatment of cardiac indications
DE10038364A1 (de) * 2000-08-05 2002-05-02 Hexal Ag Pharmazeutische, Ramipril enthaltende Brauseformulierung
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
ES2448501T3 (es) * 2002-03-06 2014-03-14 Effrx Pharmaceuticals Sa Composiciones efervescentes que comprenden bisfosfonatos
PL1750862T3 (pl) * 2004-06-04 2011-06-30 Teva Pharma Kompozycja farmaceutyczna zawierająca irbesartan
CA2715350C (en) * 2008-03-19 2017-02-14 Ratiopharm Gmbh Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1075470A (en) * 1964-07-01 1967-07-12 Miles Lab Effervescent tablet
US3906107A (en) * 1972-09-08 1975-09-16 Abbott Lab Aminoalkyl sulfate esters with diuretic activity
DE2743702A1 (de) * 1977-06-03 1978-12-14 Pharmaceutical Export Promotio Abmagerungs- oder schlankmacher- zubereitung und verfahren zu ihrer herstellung
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
AT373492B (de) * 1981-12-14 1984-01-25 Arcana Chem Pharm Verfahren zur herstellung von brausetabletten
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4832956A (en) * 1985-09-25 1989-05-23 Gerhard Gergely Disintegrating tablet and process for its preparation
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
US5073377A (en) * 1988-11-03 1991-12-17 Miles Inc. Method of preparing oral dosage forms with a granulating composition
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
US5126348A (en) * 1989-09-26 1992-06-30 The University Of Colorado Foundation, Inc. Bioavailability enhancers

Also Published As

Publication number Publication date
CA2072533A1 (en) 1993-01-02
US5393531A (en) 1995-02-28
EP0521388B1 (de) 1995-05-10
EP0521388A1 (de) 1993-01-07
JPH05186332A (ja) 1993-07-27
ATE122228T1 (de) 1995-05-15
DE59202126D1 (de) 1995-06-14
ES2074769T3 (es) 1995-09-16

Similar Documents

Publication Publication Date Title
DK0521388T3 (da) Fremgangsmåde til fremstilling af et farmaceutisk præparat med mindst to forskellige aktivstoffer samt anvendelsen af et sådant præparat
BR9913945A (pt) Composição farmacêutica para o tratamento de distúrbios agudos por meio de administração sublingual, e, processo para o tratamento de distúrbios agudos
HUP9601564A2 (hu) Irbesartant tartalmazó gyógyszerkészítmények
BR9813609A (pt) Adoçante granulado
BR9913400A (pt) Formulação oral de liberação imediata na forma sólida de um inibidor de trombina, uso de um inibidor de trombina baseado em peptìdeo de baixo peso molecular, processos para a profilaxia e/ou o tratamento de trombo-embolismo, e para a preparação de uma formulação oral de liberação imediata, e, uso de uma carga escolhida do grupo consistindo de um derivado de celulose, e um derivado de amido
WO2000001376A3 (en) Pharmaceutical compositions and their uses for treatment of demyelinating disorders
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ES2099438T3 (es) Polvo seco y estable de cefalosporina hidratada para formulacion de suspension oral.
BR0314353A (pt) Compostos, composições farmacêuticas, uso de um ou mais compostos em combinação com outros compostos farmacologicamente ativos, e, método para tratar um paciente que sofre de um distúrbio
UA70919C2 (uk) Композиція для лікування та запобігання артеріальному тромбозу з використанням інгібітора фактора ха окремо або в комбінації з препаратом, що унеможливлює агрегацію тромбоцитів
DE69126392T2 (de) Inhibitoren der Calciumaufnahme
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
ATE163265T1 (de) Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten
PT706395E (pt) Uso de ropivacaina na preparacao duma composicao farmaceutica com efeito analgesico e bloqueio motor minimo
PT991409E (pt) Composicoes farmaceuticas de libertacao controlada contendo tiagabina
SE8402199D0 (sv) Pharmazeutisches preparat enthaltend co-dergocrine und einen calcium-antagonisten
ES2082074T3 (es) 1,3-difenil-2-propin-1-onas.
Daudon et al. Drug nephrolithiasis: an unrecognized and underestimated pathology
ATE127455T1 (de) Inhibitoren der calciumaufnahme.
MX9800809A (es) Procedimiento para preparar formas de dosis solidas de dosis muy bajas del farmaco.
CA2199642A1 (en) Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
EP0817643A4 (en) COMPOUNDS AND COMPOSITIONS FOR PROVIDING ACTIVE AGENTS
Kosmachev et al. Ambivalent character of the effect of antimuscarinics at chlorophos-induced intoxication.
AR030916A1 (es) Composiciones farmaceuticas de antagonista de vasopresina y diuretico, kit que los comprenden y el uso de las mismas para la manufactura de un medicamento
CA2153570A1 (en) Pharmaceutical composition for treating nicotine dependence

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment